• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
XU Ji-yao, ZHANG Yu, ZENG Qiao. Effect and mechanism of Huangkui capsule inhibiting oxidative stress and fibrosis indicators in patients with diabetic nephropathy with stage Ⅲ-Ⅳ[J]. Journal of Clinical Nephrology, 2018, 18(5): 295-298. DOI: 10.3969/j.issn.1671-2390.2018.05.009
Citation: XU Ji-yao, ZHANG Yu, ZENG Qiao. Effect and mechanism of Huangkui capsule inhibiting oxidative stress and fibrosis indicators in patients with diabetic nephropathy with stage Ⅲ-Ⅳ[J]. Journal of Clinical Nephrology, 2018, 18(5): 295-298. DOI: 10.3969/j.issn.1671-2390.2018.05.009

Effect and mechanism of Huangkui capsule inhibiting oxidative stress and fibrosis indicators in patients with diabetic nephropathy with stage Ⅲ-Ⅳ

More Information
  • Received Date: September 10, 2017
  • Rev Recd Date: March 13, 2018
  • Available Online: May 11, 2023
  • Published Date: May 27, 2018
  • Objective To study the effect of Huangkui capsule inhibiting oxidative stress and fibrosis index in patients with diabetic kidney disease (DKD) with stage Ⅲ-Ⅳ, so as to explore the mechanism of Huangkui capsule in the treatment of DKD. Methods 100 patients with DKD with stage Ⅲ-Ⅳ from June 2014 to October 2015 were randomly divided into two groups, 50 in each group.The patients in the control group were given conventional treatment, and those in the treatment group additionally received Huangkui capsule orally, 5 capsules each time, 3 times every day for 6 months. The kidney function, and urine and serum levels of oxidative stress and fibrosis indicators were detected. Results The SCr, BUN, and β2-MG levels in two groups after treatment decreased, CCr increased, and there was statistically significant significance between two groups (P<0.05).The UAER and 24-h urine proteinin two groups after treatment were significantly lower than those before treatment, and those in the treatment group were significantly lower than those in the control group (P<0.05 for all).The MDA and MPO concentrations intwo groups after treatment were significantly lower than before treatment, SOD activity was significantly higher than before treatment,and there was statistically significant difference between two groups (P<0.05).There was no statistically significant difference in 8-OHdG in two groups before and after treatment (P>0.05).The serum IV-C, PC Ⅲ, LN and HA levels after treatment in two groups were significantly lower than before treatment, and those in study group were significantly lower than those in the control group (P<0.05 for all). Conclusions Huangkui capsule can antagonize the oxidative stress injury in kidney tissues probably by influencing the release of fibrosis factor and improving the renal fibrosis.
  • [1]
    Bhatti AB, Usman M. Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy[J]. Cureus, 2015, 7(12):393-399.
    [2]
    仝小林, 周强, 赵林华, 等. 糖尿病肾病的中医辨治经验[J]. 中华中医药杂志, 2014, 29(1):144-146.
    [3]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中国糖尿病杂志, 2014, 22(8):2-42.
    [4]
    Mogensen CE, Christensen CK, Vitinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy[J]. Diabetes, 1983, 32(Suppl 2):64-78.
    [5]
    中华中医药学会. 中医内科常见病诊疗指南·中医病证部分[M]. 北京:中国中医药出版社, 2008:8-13.
    [6]
    李泉清, 王华. 羟苯磺酸钙联合黄葵胶囊治疗老年早期糖尿病肾病蛋白尿的疗效[J]. 中国老年学杂志, 2016, 36(4):834-836.
    [7]
    杨宝峰. 药理学[M]. 北京:人民卫生出版社, 2013:336-337.
    [8]
    周静, 魏昕, 曾艳, 等. 黄葵总黄酮对C-BSA肾炎模型大鼠的作用机理研究[J]. 中药新药与临床药理, 2015, 26(6):759-764.
    [9]
    陈晓冰, 付瑞阳, 陈静. 黄葵胶囊联合盐酸贝那普利片治疗糖尿病肾病的临床观察[J]. 中国药房, 2014, 25(40):3764-3766.
    [10]
    Lindblom R, Higgins G, Coughlan M, et al. Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy[J]. Rev Diabet Stud, 2015, 12(1-2):134-156.
    [11]
    毛志敏, 万毅刚, 孙伟, 等.黄葵胶囊抑制糖尿病肾病肾组织氧化应激和p38MAPK信号通路活性改善肾纤维化的作用和机制[J]. 中国中药杂志, 2014, 39(21):4110-4117.
    [12]
    杨琳, 郭华丽. 坎地沙坦联合黄葵胶囊对早期糖尿病肾病微炎症状态的影响[J]. 中国中西医结合肾病杂志, 2012, 13(1):61-62.
    [13]
    Kim BH, Lee ES, Choi R, et al. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy[J]. Yonsei Med J, 2016, 57(3):664-673.
    [14]
    高素华, 叶赏和, 胡国华, 等. 黄葵胶囊联合雷公藤多苷对糖尿病肾病患者血纤维化指标及疗效的影响[J]. 中国老年学杂志, 2014, 34(5):1219-1220.
    [15]
    张连云, 和青松, 郭明好, 等. 黄葵胶囊联合雷公藤多甙片治疗糖尿病肾病的临床疗效观察[J]. 现代中西医结合杂志, 2010, 19(2):142-143.
  • Related Articles

    [1]Gao Ke-li, Yang Jing, Zhu Yong-jun. Research advances on the mechanism of macrophage polarization in renal interstitial fibrosis[J]. Journal of Clinical Nephrology, 2023, 23(11): 962-966. DOI: 10.3969/j.issn.1671-2390.2023.11.013
    [2]Xu Qi-ming, Lu Jian-rao. Key genes involved in renal fibrosis and renal clear cell carcinoma[J]. Journal of Clinical Nephrology, 2023, 23(6): 487-498. DOI: 10.3969/j.issn.1671-2390.2023.06.008
    [3]Xu Qi-ming, Lu Jian-rao. Identification of Hub genes in renal fibrosis[J]. Journal of Clinical Nephrology, 2023, 23(5): 388-395. DOI: 10.3969/j.issn.1671-2390.2023.05.007
    [4]Wu Feng, Wei Li. Inhibition of renal interstitial fibrosis by mulberry leaf alkaloids in rats with diabetic nephropathy[J]. Journal of Clinical Nephrology, 2022, 22(8): 666-673. DOI: 10.3969/j.issn.1671-2390.2022.08.008
    [5]Feng Yi-duo, Diao Zong-li, Liu Wen-hu. Research advances of pericytes in renal interstitial fibrosis[J]. Journal of Clinical Nephrology, 2022, 22(1): 67-71. DOI: 10.3969/j.issn.1671-2390.2022.01.013
    [6]ZHOU Lan-qi, ZHOU Jian-hua. Research progress on the role of Hedgehog signaling pathway in renal interstitial fibrosis[J]. Journal of Clinical Nephrology, 2020, 20(2): 162-165. DOI: 10.3969/j.issn.1671-2390.2020.02.014
    [7]ZHANG Man, LI Jun. A study on the relationship between Notch and TGF signal pathways in renal interstitial fibrosis[J]. Journal of Clinical Nephrology, 2019, 19(9): 705-709. DOI: 10.3969/j.issn.1671-2390.2019.09.014
    [8]SHI Chun-hua, MA Fei. Study on simvastatin improving the UUO rats renal fibrosis and anti-fibrosis plausible mechanism[J]. Journal of Clinical Nephrology, 2018, 18(11): 705-709. DOI: 10.3969/j.issn.1671-2390.2018.11.011
    [9]WU Lan, BAO Li-ping, LI Ju-shuang, WU Xiao-yan. Oridonin relieves renal damage of diabetic rats through modulation of oxidative stress and lipid metabolism[J]. Journal of Clinical Nephrology, 2017, 17(11): 692-696. DOI: 10.3969/j.issn.1671-2390.2017.11.012
    [10]LU Qing-hong, LI Yi-ming, SHI Ming. Effect of L-carnitine on oxidative stress in maintenance hemodialysis patients with anemia[J]. Journal of Clinical Nephrology, 2017, 17(10): 590-593. DOI: 10.3969/j.issn.1671-2390.2017.10.003

Catalog

    Article views (448) PDF downloads (382) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return